nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2D6—Vinorelbine—ovarian cancer	0.0222	0.255	CbGbCtD
Fingolimod—CYP3A4—Topotecan—ovarian cancer	0.0201	0.23	CbGbCtD
Fingolimod—CYP3A4—Vinorelbine—ovarian cancer	0.0141	0.162	CbGbCtD
Fingolimod—SPHK1—myometrium—ovarian cancer	0.013	0.0408	CbGeAlD
Fingolimod—CYP4F12—myometrium—ovarian cancer	0.0125	0.0392	CbGeAlD
Fingolimod—S1PR4—bone marrow—ovarian cancer	0.0117	0.0369	CbGeAlD
Fingolimod—S1PR3—decidua—ovarian cancer	0.011	0.0347	CbGeAlD
Fingolimod—S1PR5—female reproductive system—ovarian cancer	0.0104	0.0328	CbGeAlD
Fingolimod—S1PR1—epithelium—ovarian cancer	0.0103	0.0324	CbGeAlD
Fingolimod—CYP3A4—Paclitaxel—ovarian cancer	0.00993	0.114	CbGbCtD
Fingolimod—S1PR1—decidua—ovarian cancer	0.00973	0.0306	CbGeAlD
Fingolimod—S1PR3—gonad—ovarian cancer	0.00972	0.0306	CbGeAlD
Fingolimod—CYP4F12—uterine cervix—ovarian cancer	0.0097	0.0305	CbGeAlD
Fingolimod—SPHK1—decidua—ovarian cancer	0.00962	0.0303	CbGeAlD
Fingolimod—CYP4F2—bone marrow—ovarian cancer	0.00924	0.029	CbGeAlD
Fingolimod—SPHK1—endometrium—ovarian cancer	0.00914	0.0287	CbGeAlD
Fingolimod—CYP4F2—vagina—ovarian cancer	0.00885	0.0278	CbGeAlD
Fingolimod—CYP4F12—endometrium—ovarian cancer	0.00878	0.0276	CbGeAlD
Fingolimod—S1PR3—female reproductive system—ovarian cancer	0.00868	0.0273	CbGeAlD
Fingolimod—SPHK1—gonad—ovarian cancer	0.00847	0.0266	CbGeAlD
Fingolimod—SPHK1—uterus—ovarian cancer	0.00842	0.0265	CbGeAlD
Fingolimod—CYP2D6—Doxorubicin—ovarian cancer	0.00842	0.0964	CbGbCtD
Fingolimod—CYP4F12—uterus—ovarian cancer	0.00809	0.0254	CbGeAlD
Fingolimod—S1PR3—female gonad—ovarian cancer	0.0079	0.0248	CbGeAlD
Fingolimod—S1PR1—female reproductive system—ovarian cancer	0.00765	0.0241	CbGeAlD
Fingolimod—SPHK1—female reproductive system—ovarian cancer	0.00757	0.0238	CbGeAlD
Fingolimod—CYP4F12—female reproductive system—ovarian cancer	0.00727	0.0229	CbGeAlD
Fingolimod—S1PR4—lymph node—ovarian cancer	0.00727	0.0229	CbGeAlD
Fingolimod—CYP3A4—Docetaxel—ovarian cancer	0.00718	0.0823	CbGbCtD
Fingolimod—S1PR3—testis—ovarian cancer	0.007	0.022	CbGeAlD
Fingolimod—S1PR1—female gonad—ovarian cancer	0.00696	0.0219	CbGeAlD
Fingolimod—S1PR1—vagina—ovarian cancer	0.00692	0.0218	CbGeAlD
Fingolimod—SPHK1—female gonad—ovarian cancer	0.00689	0.0217	CbGeAlD
Fingolimod—CYP4F12—bone marrow—ovarian cancer	0.00686	0.0216	CbGeAlD
Fingolimod—SPHK1—vagina—ovarian cancer	0.00684	0.0215	CbGeAlD
Fingolimod—CYP4F12—female gonad—ovarian cancer	0.00662	0.0208	CbGeAlD
Fingolimod—CYP4F12—vagina—ovarian cancer	0.00658	0.0207	CbGeAlD
Fingolimod—S1PR1—testis—ovarian cancer	0.00617	0.0194	CbGeAlD
Fingolimod—SPHK1—testis—ovarian cancer	0.00611	0.0192	CbGeAlD
Fingolimod—S1PR5—lymph node—ovarian cancer	0.00611	0.0192	CbGeAlD
Fingolimod—CYP4F12—testis—ovarian cancer	0.00587	0.0185	CbGeAlD
Fingolimod—CYP3A4—Doxorubicin—ovarian cancer	0.00535	0.0613	CbGbCtD
Fingolimod—S1PR3—lymph node—ovarian cancer	0.00508	0.016	CbGeAlD
Fingolimod—S1PR1—lymph node—ovarian cancer	0.00447	0.0141	CbGeAlD
Fingolimod—SPHK1—lymph node—ovarian cancer	0.00443	0.0139	CbGeAlD
Fingolimod—CYP4F12—lymph node—ovarian cancer	0.00425	0.0134	CbGeAlD
Fingolimod—Aspartate aminotransferase increased—Topotecan—ovarian cancer	0.00194	0.0071	CcSEcCtD
Fingolimod—Lymphopenia—Epirubicin—ovarian cancer	0.00191	0.00698	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Topotecan—ovarian cancer	0.0019	0.00696	CcSEcCtD
Fingolimod—Cerebrovascular accident—Vinorelbine—ovarian cancer	0.00188	0.00689	CcSEcCtD
Fingolimod—Pneumonia—Chlorambucil—ovarian cancer	0.00188	0.00687	CcSEcCtD
Fingolimod—Lymphopenia—Doxorubicin—ovarian cancer	0.00177	0.00646	CcSEcCtD
Fingolimod—Atrioventricular block—Paclitaxel—ovarian cancer	0.00176	0.00645	CcSEcCtD
Fingolimod—Pneumonia—Topotecan—ovarian cancer	0.00167	0.00611	CcSEcCtD
Fingolimod—Infestation NOS—Topotecan—ovarian cancer	0.00166	0.00608	CcSEcCtD
Fingolimod—Infestation—Topotecan—ovarian cancer	0.00166	0.00608	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Vinorelbine—ovarian cancer	0.00166	0.00608	CcSEcCtD
Fingolimod—Alopecia—Chlorambucil—ovarian cancer	0.00148	0.00542	CcSEcCtD
Fingolimod—Weight decreased—Vinorelbine—ovarian cancer	0.00144	0.00528	CcSEcCtD
Fingolimod—Connective tissue disorder—Melphalan—ovarian cancer	0.00143	0.00525	CcSEcCtD
Fingolimod—Pneumonia—Vinorelbine—ovarian cancer	0.00143	0.00523	CcSEcCtD
Fingolimod—Infestation—Vinorelbine—ovarian cancer	0.00142	0.0052	CcSEcCtD
Fingolimod—Infestation NOS—Vinorelbine—ovarian cancer	0.00142	0.0052	CcSEcCtD
Fingolimod—Eye pain—Paclitaxel—ovarian cancer	0.00137	0.00503	CcSEcCtD
Fingolimod—Angiopathy—Topotecan—ovarian cancer	0.00135	0.00495	CcSEcCtD
Fingolimod—Mediastinal disorder—Topotecan—ovarian cancer	0.00134	0.00492	CcSEcCtD
Fingolimod—Alopecia—Topotecan—ovarian cancer	0.00132	0.00482	CcSEcCtD
Fingolimod—Mediastinal disorder—Melphalan—ovarian cancer	0.00132	0.00481	CcSEcCtD
Fingolimod—Leukopenia—Chlorambucil—ovarian cancer	0.00131	0.00478	CcSEcCtD
Fingolimod—Herpes zoster—Epirubicin—ovarian cancer	0.0013	0.00475	CcSEcCtD
Fingolimod—Alopecia—Melphalan—ovarian cancer	0.00129	0.00472	CcSEcCtD
Fingolimod—Cerebrovascular accident—Paclitaxel—ovarian cancer	0.00127	0.00463	CcSEcCtD
Fingolimod—Back pain—Topotecan—ovarian cancer	0.00126	0.00459	CcSEcCtD
Fingolimod—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00125	0.00459	CcSEcCtD
Fingolimod—CYP2E1—female reproductive system—ovarian cancer	0.00123	0.00386	CbGeAlD
Fingolimod—Herpes zoster—Doxorubicin—ovarian cancer	0.0012	0.00439	CcSEcCtD
Fingolimod—Cardiac disorder—Vinorelbine—ovarian cancer	0.00118	0.00433	CcSEcCtD
Fingolimod—Infection—Chlorambucil—ovarian cancer	0.00118	0.00433	CcSEcCtD
Fingolimod—Cardiac arrest—Paclitaxel—ovarian cancer	0.00118	0.00432	CcSEcCtD
Fingolimod—Leukopenia—Topotecan—ovarian cancer	0.00116	0.00425	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—ovarian cancer	0.00116	0.00425	CcSEcCtD
Fingolimod—Angiopathy—Vinorelbine—ovarian cancer	0.00116	0.00423	CcSEcCtD
Fingolimod—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00115	0.00421	CcSEcCtD
Fingolimod—Liver function test abnormal—Paclitaxel—ovarian cancer	0.00114	0.00419	CcSEcCtD
Fingolimod—Leukopenia—Melphalan—ovarian cancer	0.00114	0.00416	CcSEcCtD
Fingolimod—Cough—Topotecan—ovarian cancer	0.00113	0.00414	CcSEcCtD
Fingolimod—Alopecia—Vinorelbine—ovarian cancer	0.00113	0.00412	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.00112	0.00409	CcSEcCtD
Fingolimod—Cough—Melphalan—ovarian cancer	0.00111	0.00406	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.0011	0.00402	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.00109	0.004	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00107	0.00393	CcSEcCtD
Fingolimod—Back pain—Vinorelbine—ovarian cancer	0.00107	0.00393	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—ovarian cancer	0.00107	0.00393	CcSEcCtD
Fingolimod—Influenza—Paclitaxel—ovarian cancer	0.00107	0.00392	CcSEcCtD
Fingolimod—Infection—Topotecan—ovarian cancer	0.00105	0.00385	CcSEcCtD
Fingolimod—Nervous system disorder—Topotecan—ovarian cancer	0.00104	0.0038	CcSEcCtD
Fingolimod—Migraine—Docetaxel—ovarian cancer	0.00103	0.00379	CcSEcCtD
Fingolimod—Bronchitis—Paclitaxel—ovarian cancer	0.00103	0.00377	CcSEcCtD
Fingolimod—Infection—Melphalan—ovarian cancer	0.00103	0.00377	CcSEcCtD
Fingolimod—Skin disorder—Topotecan—ovarian cancer	0.00103	0.00377	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00103	0.00376	CcSEcCtD
Fingolimod—Fatigue—Chlorambucil—ovarian cancer	0.00103	0.00375	CcSEcCtD
Fingolimod—Skin disorder—Melphalan—ovarian cancer	0.00101	0.00369	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—ovarian cancer	0.00101	0.00368	CcSEcCtD
Fingolimod—Leukopenia—Vinorelbine—ovarian cancer	0.000994	0.00364	CcSEcCtD
Fingolimod—CYP2E1—testis—ovarian cancer	0.00099	0.00311	CbGeAlD
Fingolimod—CYP3A4—female reproductive system—ovarian cancer	0.000987	0.0031	CbGeAlD
Fingolimod—Palpitations—Vinorelbine—ovarian cancer	0.000981	0.00359	CcSEcCtD
Fingolimod—CYP2D6—female reproductive system—ovarian cancer	0.000971	0.00305	CbGeAlD
Fingolimod—Liver function test abnormal—Docetaxel—ovarian cancer	0.00097	0.00355	CcSEcCtD
Fingolimod—Weight decreased—Paclitaxel—ovarian cancer	0.00097	0.00355	CcSEcCtD
Fingolimod—Hypotension—Melphalan—ovarian cancer	0.000969	0.00355	CcSEcCtD
Fingolimod—Cough—Vinorelbine—ovarian cancer	0.000969	0.00355	CcSEcCtD
Fingolimod—Pneumonia—Paclitaxel—ovarian cancer	0.000961	0.00352	CcSEcCtD
Fingolimod—Hypertension—Vinorelbine—ovarian cancer	0.000959	0.00351	CcSEcCtD
Fingolimod—Infestation NOS—Paclitaxel—ovarian cancer	0.000956	0.0035	CcSEcCtD
Fingolimod—Infestation—Paclitaxel—ovarian cancer	0.000956	0.0035	CcSEcCtD
Fingolimod—Depression—Paclitaxel—ovarian cancer	0.000953	0.00349	CcSEcCtD
Fingolimod—Paraesthesia—Topotecan—ovarian cancer	0.000951	0.00348	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000947	0.00346	CcSEcCtD
Fingolimod—Dyspnoea—Topotecan—ovarian cancer	0.000944	0.00346	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000939	0.00344	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—ovarian cancer	0.000932	0.00341	CcSEcCtD
Fingolimod—Paraesthesia—Melphalan—ovarian cancer	0.000931	0.00341	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000927	0.00339	CcSEcCtD
Fingolimod—Dyspnoea—Melphalan—ovarian cancer	0.000925	0.00338	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000915	0.00335	CcSEcCtD
Fingolimod—Fatigue—Topotecan—ovarian cancer	0.000913	0.00334	CcSEcCtD
Fingolimod—Infection—Vinorelbine—ovarian cancer	0.0009	0.00329	CcSEcCtD
Fingolimod—Sinusitis—Paclitaxel—ovarian cancer	0.000897	0.00328	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000896	0.00328	CcSEcCtD
Fingolimod—Fatigue—Melphalan—ovarian cancer	0.000894	0.00327	CcSEcCtD
Fingolimod—Nervous system disorder—Vinorelbine—ovarian cancer	0.000889	0.00325	CcSEcCtD
Fingolimod—CYP2D6—female gonad—ovarian cancer	0.000883	0.00278	CbGeAlD
Fingolimod—Skin disorder—Vinorelbine—ovarian cancer	0.00088	0.00322	CcSEcCtD
Fingolimod—Bradycardia—Paclitaxel—ovarian cancer	0.000873	0.0032	CcSEcCtD
Fingolimod—Asthenia—Chlorambucil—ovarian cancer	0.000854	0.00312	CcSEcCtD
Fingolimod—Hypotension—Vinorelbine—ovarian cancer	0.000847	0.0031	CcSEcCtD
Fingolimod—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000843	0.00309	CcSEcCtD
Fingolimod—Pruritus—Chlorambucil—ovarian cancer	0.000842	0.00308	CcSEcCtD
Fingolimod—Weight decreased—Docetaxel—ovarian cancer	0.000822	0.00301	CcSEcCtD
Fingolimod—Pneumonia—Docetaxel—ovarian cancer	0.000815	0.00298	CcSEcCtD
Fingolimod—Diarrhoea—Chlorambucil—ovarian cancer	0.000814	0.00298	CcSEcCtD
Fingolimod—Paraesthesia—Vinorelbine—ovarian cancer	0.000814	0.00298	CcSEcCtD
Fingolimod—Infestation NOS—Docetaxel—ovarian cancer	0.00081	0.00296	CcSEcCtD
Fingolimod—Infestation—Docetaxel—ovarian cancer	0.00081	0.00296	CcSEcCtD
Fingolimod—Dyspnoea—Vinorelbine—ovarian cancer	0.000808	0.00296	CcSEcCtD
Fingolimod—Eye disorder—Paclitaxel—ovarian cancer	0.000802	0.00293	CcSEcCtD
Fingolimod—Cardiac disorder—Paclitaxel—ovarian cancer	0.000796	0.00291	CcSEcCtD
Fingolimod—Eczema—Epirubicin—ovarian cancer	0.000789	0.00289	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—ovarian cancer	0.000785	0.00287	CcSEcCtD
Fingolimod—CYP2D6—testis—ovarian cancer	0.000784	0.00246	CbGeAlD
Fingolimod—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000782	0.00286	CcSEcCtD
Fingolimod—Fatigue—Vinorelbine—ovarian cancer	0.000781	0.00286	CcSEcCtD
Fingolimod—Angiopathy—Paclitaxel—ovarian cancer	0.000778	0.00285	CcSEcCtD
Fingolimod—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000773	0.00283	CcSEcCtD
Fingolimod—Asthenia—Topotecan—ovarian cancer	0.00076	0.00278	CcSEcCtD
Fingolimod—Alopecia—Paclitaxel—ovarian cancer	0.000758	0.00277	CcSEcCtD
Fingolimod—Mental disorder—Paclitaxel—ovarian cancer	0.000752	0.00275	CcSEcCtD
Fingolimod—Pruritus—Topotecan—ovarian cancer	0.000749	0.00274	CcSEcCtD
Fingolimod—Asthenia—Melphalan—ovarian cancer	0.000744	0.00272	CcSEcCtD
Fingolimod—Pruritus—Melphalan—ovarian cancer	0.000734	0.00269	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—ovarian cancer	0.00073	0.00267	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—ovarian cancer	0.000727	0.00266	CcSEcCtD
Fingolimod—Diarrhoea—Topotecan—ovarian cancer	0.000725	0.00265	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000724	0.00265	CcSEcCtD
Fingolimod—Back pain—Paclitaxel—ovarian cancer	0.000722	0.00264	CcSEcCtD
Fingolimod—Connective tissue disorder—Docetaxel—ovarian cancer	0.000715	0.00261	CcSEcCtD
Fingolimod—Diarrhoea—Melphalan—ovarian cancer	0.00071	0.0026	CcSEcCtD
Fingolimod—Vision blurred—Paclitaxel—ovarian cancer	0.000704	0.00258	CcSEcCtD
Fingolimod—Dizziness—Topotecan—ovarian cancer	0.000701	0.00256	CcSEcCtD
Fingolimod—Migraine—Epirubicin—ovarian cancer	0.000698	0.00255	CcSEcCtD
Fingolimod—Eye disorder—Docetaxel—ovarian cancer	0.00068	0.00249	CcSEcCtD
Fingolimod—Cardiac disorder—Docetaxel—ovarian cancer	0.000675	0.00247	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—ovarian cancer	0.000674	0.00247	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000669	0.00245	CcSEcCtD
Fingolimod—Leukopenia—Paclitaxel—ovarian cancer	0.000669	0.00245	CcSEcCtD
Fingolimod—Headache—Topotecan—ovarian cancer	0.000664	0.00243	CcSEcCtD
Fingolimod—Palpitations—Paclitaxel—ovarian cancer	0.00066	0.00242	CcSEcCtD
Fingolimod—Angiopathy—Docetaxel—ovarian cancer	0.00066	0.00241	CcSEcCtD
Fingolimod—Mediastinal disorder—Docetaxel—ovarian cancer	0.000655	0.0024	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—ovarian cancer	0.000655	0.0024	CcSEcCtD
Fingolimod—Cough—Paclitaxel—ovarian cancer	0.000652	0.00238	CcSEcCtD
Fingolimod—Asthenia—Vinorelbine—ovarian cancer	0.00065	0.00238	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—ovarian cancer	0.000646	0.00236	CcSEcCtD
Fingolimod—Hypertension—Paclitaxel—ovarian cancer	0.000645	0.00236	CcSEcCtD
Fingolimod—Alopecia—Docetaxel—ovarian cancer	0.000643	0.00235	CcSEcCtD
Fingolimod—Pruritus—Vinorelbine—ovarian cancer	0.000641	0.00235	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000638	0.00234	CcSEcCtD
Fingolimod—Mental disorder—Docetaxel—ovarian cancer	0.000637	0.00233	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000631	0.00231	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000625	0.00229	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—ovarian cancer	0.000624	0.00228	CcSEcCtD
Fingolimod—Diarrhoea—Vinorelbine—ovarian cancer	0.00062	0.00227	CcSEcCtD
Fingolimod—Influenza—Epirubicin—ovarian cancer	0.000613	0.00224	CcSEcCtD
Fingolimod—Back pain—Docetaxel—ovarian cancer	0.000612	0.00224	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000606	0.00222	CcSEcCtD
Fingolimod—Infection—Paclitaxel—ovarian cancer	0.000606	0.00222	CcSEcCtD
Fingolimod—Dizziness—Vinorelbine—ovarian cancer	0.000599	0.00219	CcSEcCtD
Fingolimod—Nervous system disorder—Paclitaxel—ovarian cancer	0.000598	0.00219	CcSEcCtD
Fingolimod—Skin disorder—Paclitaxel—ovarian cancer	0.000592	0.00217	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000591	0.00216	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—ovarian cancer	0.000589	0.00216	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000579	0.00212	CcSEcCtD
Fingolimod—Hypotension—Paclitaxel—ovarian cancer	0.00057	0.00208	CcSEcCtD
Fingolimod—Headache—Vinorelbine—ovarian cancer	0.000568	0.00208	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—ovarian cancer	0.000567	0.00207	CcSEcCtD
Fingolimod—Leukopenia—Docetaxel—ovarian cancer	0.000567	0.00207	CcSEcCtD
Fingolimod—Palpitations—Docetaxel—ovarian cancer	0.000559	0.00205	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—ovarian cancer	0.000554	0.00203	CcSEcCtD
Fingolimod—Cough—Docetaxel—ovarian cancer	0.000552	0.00202	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—ovarian cancer	0.00055	0.00201	CcSEcCtD
Fingolimod—Paraesthesia—Paclitaxel—ovarian cancer	0.000547	0.002	CcSEcCtD
Fingolimod—Hypertension—Docetaxel—ovarian cancer	0.000547	0.002	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—ovarian cancer	0.000546	0.002	CcSEcCtD
Fingolimod—Infestation—Epirubicin—ovarian cancer	0.000546	0.002	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—ovarian cancer	0.000545	0.002	CcSEcCtD
Fingolimod—Dyspnoea—Paclitaxel—ovarian cancer	0.000543	0.00199	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000535	0.00196	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000526	0.00193	CcSEcCtD
Fingolimod—Fatigue—Paclitaxel—ovarian cancer	0.000526	0.00192	CcSEcCtD
Fingolimod—Infection—Docetaxel—ovarian cancer	0.000513	0.00188	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—ovarian cancer	0.000513	0.00188	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—ovarian cancer	0.000513	0.00188	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—ovarian cancer	0.000508	0.00186	CcSEcCtD
Fingolimod—Nervous system disorder—Docetaxel—ovarian cancer	0.000507	0.00185	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—ovarian cancer	0.000506	0.00185	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—ovarian cancer	0.000506	0.00185	CcSEcCtD
Fingolimod—Skin disorder—Docetaxel—ovarian cancer	0.000502	0.00184	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—ovarian cancer	0.000499	0.00183	CcSEcCtD
Fingolimod—Hypotension—Docetaxel—ovarian cancer	0.000483	0.00177	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—ovarian cancer	0.000482	0.00176	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—ovarian cancer	0.000474	0.00174	CcSEcCtD
Fingolimod—Paraesthesia—Docetaxel—ovarian cancer	0.000464	0.0017	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—ovarian cancer	0.000462	0.00169	CcSEcCtD
Fingolimod—Dyspnoea—Docetaxel—ovarian cancer	0.000461	0.00169	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—ovarian cancer	0.000458	0.00168	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—ovarian cancer	0.000455	0.00167	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000446	0.00163	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000446	0.00163	CcSEcCtD
Fingolimod—Fatigue—Docetaxel—ovarian cancer	0.000445	0.00163	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—ovarian cancer	0.000445	0.00163	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—ovarian cancer	0.000442	0.00162	CcSEcCtD
Fingolimod—Asthenia—Paclitaxel—ovarian cancer	0.000437	0.0016	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—ovarian cancer	0.000433	0.00159	CcSEcCtD
Fingolimod—Pruritus—Paclitaxel—ovarian cancer	0.000431	0.00158	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—ovarian cancer	0.00043	0.00157	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—ovarian cancer	0.000424	0.00155	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—ovarian cancer	0.000421	0.00154	CcSEcCtD
Fingolimod—Diarrhoea—Paclitaxel—ovarian cancer	0.000417	0.00153	CcSEcCtD
Fingolimod—Back pain—Epirubicin—ovarian cancer	0.000413	0.00151	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—ovarian cancer	0.000412	0.00151	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000409	0.0015	CcSEcCtD
Fingolimod—Dizziness—Paclitaxel—ovarian cancer	0.000403	0.00147	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—ovarian cancer	0.000402	0.00147	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—ovarian cancer	0.000401	0.00147	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—ovarian cancer	0.000398	0.00145	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—ovarian cancer	0.000382	0.0014	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—ovarian cancer	0.000382	0.0014	CcSEcCtD
Fingolimod—Headache—Paclitaxel—ovarian cancer	0.000382	0.0014	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—ovarian cancer	0.000377	0.00138	CcSEcCtD
Fingolimod—Cough—Epirubicin—ovarian cancer	0.000373	0.00136	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—ovarian cancer	0.000372	0.00136	CcSEcCtD
Fingolimod—Asthenia—Docetaxel—ovarian cancer	0.000371	0.00136	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—ovarian cancer	0.000369	0.00135	CcSEcCtD
Fingolimod—Pruritus—Docetaxel—ovarian cancer	0.000366	0.00134	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000361	0.00132	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—ovarian cancer	0.000354	0.00129	CcSEcCtD
Fingolimod—Diarrhoea—Docetaxel—ovarian cancer	0.000353	0.00129	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—ovarian cancer	0.000349	0.00128	CcSEcCtD
Fingolimod—Infection—Epirubicin—ovarian cancer	0.000346	0.00127	CcSEcCtD
Fingolimod—Cough—Doxorubicin—ovarian cancer	0.000345	0.00126	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—ovarian cancer	0.000342	0.00125	CcSEcCtD
Fingolimod—Dizziness—Docetaxel—ovarian cancer	0.000342	0.00125	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—ovarian cancer	0.000341	0.00125	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—ovarian cancer	0.000338	0.00124	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000334	0.00122	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—ovarian cancer	0.000326	0.00119	CcSEcCtD
Fingolimod—Headache—Docetaxel—ovarian cancer	0.000324	0.00118	CcSEcCtD
Fingolimod—Infection—Doxorubicin—ovarian cancer	0.00032	0.00117	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—ovarian cancer	0.000316	0.00116	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—ovarian cancer	0.000313	0.00115	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—ovarian cancer	0.000313	0.00115	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—ovarian cancer	0.000311	0.00114	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—ovarian cancer	0.000301	0.0011	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000301	0.0011	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—ovarian cancer	0.0003	0.0011	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—ovarian cancer	0.00029	0.00106	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—ovarian cancer	0.000287	0.00105	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000278	0.00102	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—ovarian cancer	0.000278	0.00102	CcSEcCtD
Fingolimod—Asthenia—Epirubicin—ovarian cancer	0.00025	0.000915	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—ovarian cancer	0.000247	0.000902	CcSEcCtD
Fingolimod—Diarrhoea—Epirubicin—ovarian cancer	0.000238	0.000872	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—ovarian cancer	0.000231	0.000847	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—ovarian cancer	0.00023	0.000843	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—ovarian cancer	0.000228	0.000835	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—ovarian cancer	0.000221	0.000807	CcSEcCtD
Fingolimod—Headache—Epirubicin—ovarian cancer	0.000218	0.000799	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—ovarian cancer	0.000213	0.00078	CcSEcCtD
Fingolimod—Headache—Doxorubicin—ovarian cancer	0.000202	0.000739	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—MAPK3—ovarian cancer	0.000134	0.000417	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CB—ovarian cancer	0.000134	0.000416	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CD—ovarian cancer	0.000132	0.000412	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CG—ovarian cancer	0.000129	0.000403	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ESR1—ovarian cancer	0.000129	0.000402	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—MAPK3—ovarian cancer	0.000129	0.000401	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—MAPK3—ovarian cancer	0.000129	0.000401	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TERT—ovarian cancer	0.000128	0.000399	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NME2—ovarian cancer	0.000128	0.000397	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—MAPK1—ovarian cancer	0.000127	0.000396	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—ovarian cancer	0.000127	0.000396	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6ST—ovarian cancer	0.000127	0.000396	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CD—ovarian cancer	0.000123	0.000382	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—MAPK1—ovarian cancer	0.000123	0.000382	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—MAPK1—ovarian cancer	0.000123	0.000382	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—ovarian cancer	0.000123	0.000382	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—ovarian cancer	0.000123	0.000382	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APC—ovarian cancer	0.000122	0.00038	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CG—ovarian cancer	0.000122	0.00038	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NRAS—ovarian cancer	0.000122	0.00038	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000122	0.000379	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—ovarian cancer	0.00012	0.000374	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CAV1—ovarian cancer	0.000119	0.00037	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CD—ovarian cancer	0.000118	0.000368	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CD—ovarian cancer	0.000118	0.000368	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000117	0.000365	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000117	0.000365	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—MAPK3—ovarian cancer	0.000117	0.000364	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—ovarian cancer	0.000116	0.00036	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—ovarian cancer	0.000116	0.00036	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTEN—ovarian cancer	0.000116	0.000359	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CB—ovarian cancer	0.000115	0.000359	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ESR1—ovarian cancer	0.000114	0.000356	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CD—ovarian cancer	0.000114	0.000354	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6ST—ovarian cancer	0.000113	0.00035	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—MAPK1—ovarian cancer	0.000111	0.000347	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—ovarian cancer	0.000111	0.000346	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PIK3CA—ovarian cancer	0.000111	0.000344	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB2—ovarian cancer	0.000109	0.000338	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APC—ovarian cancer	0.000108	0.000337	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CG—ovarian cancer	0.000108	0.000337	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CD—ovarian cancer	0.000107	0.000334	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MTOR—ovarian cancer	0.000107	0.000333	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CB—ovarian cancer	0.000107	0.000333	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CA—ovarian cancer	0.000106	0.000331	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CA—ovarian cancer	0.000106	0.000331	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000106	0.000331	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—ovarian cancer	0.000105	0.000327	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB2—ovarian cancer	0.000105	0.000325	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB2—ovarian cancer	0.000105	0.000325	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CB—ovarian cancer	0.000103	0.000321	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MTOR—ovarian cancer	0.000103	0.000321	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CB—ovarian cancer	0.000103	0.000321	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MTOR—ovarian cancer	0.000103	0.000321	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—ovarian cancer	0.000103	0.00032	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—ovarian cancer	0.000102	0.000318	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1B—ovarian cancer	0.000101	0.000313	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTEN—ovarian cancer	9.97e-05	0.00031	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—ovarian cancer	9.95e-05	0.00031	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CB—ovarian cancer	9.91e-05	0.000308	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—ovarian cancer	9.91e-05	0.000308	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—ovarian cancer	9.91e-05	0.000308	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—ovarian cancer	9.86e-05	0.000307	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—ovarian cancer	9.85e-05	0.000306	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—ovarian cancer	9.85e-05	0.000306	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—ovarian cancer	9.84e-05	0.000306	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—ovarian cancer	9.79e-05	0.000305	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	9.71e-05	0.000302	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1B—ovarian cancer	9.68e-05	0.000301	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1B—ovarian cancer	9.68e-05	0.000301	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—ovarian cancer	9.67e-05	0.000301	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—ovarian cancer	9.59e-05	0.000298	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—ovarian cancer	9.58e-05	0.000298	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—ovarian cancer	9.58e-05	0.000298	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	9.57e-05	0.000298	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CD—ovarian cancer	9.51e-05	0.000296	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—ovarian cancer	9.5e-05	0.000296	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—ovarian cancer	9.49e-05	0.000295	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—ovarian cancer	9.49e-05	0.000295	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—ovarian cancer	9.49e-05	0.000295	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—ovarian cancer	9.47e-05	0.000295	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—ovarian cancer	9.47e-05	0.000295	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—ovarian cancer	9.43e-05	0.000293	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—ovarian cancer	9.43e-05	0.000293	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MTOR—ovarian cancer	9.37e-05	0.000291	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CB—ovarian cancer	9.37e-05	0.000291	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—ovarian cancer	9.31e-05	0.00029	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTEN—ovarian cancer	9.26e-05	0.000288	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—ovarian cancer	9.24e-05	0.000287	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—ovarian cancer	9.24e-05	0.000287	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—ovarian cancer	9.15e-05	0.000285	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—ovarian cancer	9.15e-05	0.000285	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NME2—ovarian cancer	9.05e-05	0.000282	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—ovarian cancer	9.03e-05	0.000281	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—ovarian cancer	9e-05	0.00028	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—ovarian cancer	8.97e-05	0.000279	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—ovarian cancer	8.97e-05	0.000279	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—ovarian cancer	8.94e-05	0.000278	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTEN—ovarian cancer	8.91e-05	0.000277	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTEN—ovarian cancer	8.91e-05	0.000277	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1B—ovarian cancer	8.79e-05	0.000273	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—ovarian cancer	8.7e-05	0.000271	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—ovarian cancer	8.7e-05	0.000271	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—ovarian cancer	8.7e-05	0.000271	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—ovarian cancer	8.62e-05	0.000268	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—ovarian cancer	8.6e-05	0.000268	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTEN—ovarian cancer	8.57e-05	0.000267	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—ovarian cancer	8.56e-05	0.000266	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—ovarian cancer	8.4e-05	0.000261	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—ovarian cancer	8.39e-05	0.000261	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—ovarian cancer	8.36e-05	0.00026	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—ovarian cancer	8.3e-05	0.000258	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CB—ovarian cancer	8.29e-05	0.000258	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MTOR—ovarian cancer	8.29e-05	0.000258	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—ovarian cancer	8.28e-05	0.000258	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—ovarian cancer	8.26e-05	0.000257	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYTB—ovarian cancer	8.22e-05	0.000256	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—ovarian cancer	8.15e-05	0.000254	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—ovarian cancer	8.14e-05	0.000253	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—ovarian cancer	8.09e-05	0.000252	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—ovarian cancer	8.05e-05	0.00025	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—ovarian cancer	8.05e-05	0.00025	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—ovarian cancer	7.97e-05	0.000248	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—ovarian cancer	7.97e-05	0.000248	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—ovarian cancer	7.97e-05	0.000248	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—ovarian cancer	7.95e-05	0.000247	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—ovarian cancer	7.95e-05	0.000247	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK3—ovarian cancer	7.91e-05	0.000246	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—ovarian cancer	7.9e-05	0.000246	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1B—ovarian cancer	7.78e-05	0.000242	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—ovarian cancer	7.7e-05	0.000239	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—ovarian cancer	7.63e-05	0.000237	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK3—ovarian cancer	7.62e-05	0.000237	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK3—ovarian cancer	7.62e-05	0.000237	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—ovarian cancer	7.61e-05	0.000237	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK1—ovarian cancer	7.53e-05	0.000234	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—ovarian cancer	7.53e-05	0.000234	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—ovarian cancer	7.42e-05	0.000231	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—ovarian cancer	7.41e-05	0.00023	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—ovarian cancer	7.41e-05	0.00023	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—ovarian cancer	7.35e-05	0.000229	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—ovarian cancer	7.31e-05	0.000227	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK1—ovarian cancer	7.25e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK1—ovarian cancer	7.25e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—ovarian cancer	7.25e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—ovarian cancer	7.25e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—ovarian cancer	7.24e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—ovarian cancer	7.22e-05	0.000225	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—ovarian cancer	7.21e-05	0.000224	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPP1CC—ovarian cancer	7.19e-05	0.000224	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BRIP1—ovarian cancer	7.19e-05	0.000224	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—ovarian cancer	7.16e-05	0.000223	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—ovarian cancer	7.11e-05	0.000221	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—ovarian cancer	7.03e-05	0.000219	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK3—ovarian cancer	6.92e-05	0.000215	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—ovarian cancer	6.84e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—ovarian cancer	6.84e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—ovarian cancer	6.73e-05	0.000209	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—ovarian cancer	6.66e-05	0.000207	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK1—ovarian cancer	6.58e-05	0.000205	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—ovarian cancer	6.58e-05	0.000205	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—ovarian cancer	6.53e-05	0.000203	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—ovarian cancer	6.47e-05	0.000201	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—ovarian cancer	6.41e-05	0.000199	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—ovarian cancer	6.39e-05	0.000199	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—ovarian cancer	6.32e-05	0.000197	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—ovarian cancer	6.29e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—ovarian cancer	6.29e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—ovarian cancer	6.22e-05	0.000193	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK3—ovarian cancer	6.12e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—ovarian cancer	6.08e-05	0.000189	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—ovarian cancer	6.08e-05	0.000189	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—ovarian cancer	6.04e-05	0.000188	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—ovarian cancer	6.04e-05	0.000188	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—ovarian cancer	5.95e-05	0.000185	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NME2—ovarian cancer	5.92e-05	0.000184	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYTB—ovarian cancer	5.83e-05	0.000181	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK1—ovarian cancer	5.82e-05	0.000181	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—ovarian cancer	5.82e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—ovarian cancer	5.82e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—ovarian cancer	5.82e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—ovarian cancer	5.79e-05	0.00018	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—ovarian cancer	5.75e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—ovarian cancer	5.71e-05	0.000178	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—ovarian cancer	5.57e-05	0.000173	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—ovarian cancer	5.57e-05	0.000173	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—ovarian cancer	5.52e-05	0.000172	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—ovarian cancer	5.5e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—ovarian cancer	5.34e-05	0.000166	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—ovarian cancer	5.28e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—ovarian cancer	5.14e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—ovarian cancer	5.14e-05	0.00016	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPP1CC—ovarian cancer	5.1e-05	0.000159	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BRIP1—ovarian cancer	5.1e-05	0.000159	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—ovarian cancer	5.06e-05	0.000157	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—ovarian cancer	5.05e-05	0.000157	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—ovarian cancer	4.94e-05	0.000154	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—ovarian cancer	4.89e-05	0.000152	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—YAP1—ovarian cancer	4.82e-05	0.00015	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—ovarian cancer	4.68e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—ovarian cancer	4.66e-05	0.000145	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—ovarian cancer	4.48e-05	0.000139	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—ovarian cancer	4.13e-05	0.000128	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FASN—ovarian cancer	3.93e-05	0.000122	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A5—ovarian cancer	3.86e-05	0.00012	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYTB—ovarian cancer	3.81e-05	0.000119	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A1—ovarian cancer	3.73e-05	0.000116	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1B1—ovarian cancer	3.58e-05	0.000111	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—YAP1—ovarian cancer	3.42e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.33e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.33e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	3.17e-05	9.87e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—ovarian cancer	2.95e-05	9.17e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—ovarian cancer	2.89e-05	9e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FASN—ovarian cancer	2.79e-05	8.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.74e-05	8.53e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.65e-05	8.24e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1B1—ovarian cancer	2.54e-05	7.9e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAV1—ovarian cancer	2.33e-05	7.25e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	2.25e-05	7.01e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—YAP1—ovarian cancer	2.24e-05	6.96e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—ovarian cancer	2.12e-05	6.61e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—ovarian cancer	2.09e-05	6.51e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—ovarian cancer	2.05e-05	6.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.87e-05	5.81e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FASN—ovarian cancer	1.82e-05	5.67e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.79e-05	5.58e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.73e-05	5.39e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.66e-05	5.16e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAV1—ovarian cancer	1.65e-05	5.15e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.63e-05	5.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.51e-05	4.69e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.47e-05	4.58e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—ovarian cancer	1.41e-05	4.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.37e-05	4.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—ovarian cancer	1.34e-05	4.18e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.33e-05	4.12e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.15e-05	3.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAV1—ovarian cancer	1.08e-05	3.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—ovarian cancer	9.98e-06	3.1e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—ovarian cancer	9.92e-06	3.09e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—ovarian cancer	9.85e-06	3.07e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CD—ovarian cancer	8.66e-06	2.7e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—ovarian cancer	8.11e-06	2.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CB—ovarian cancer	7.55e-06	2.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—ovarian cancer	7.04e-06	2.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—ovarian cancer	6.53e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—ovarian cancer	5.75e-06	1.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.6e-06	1.43e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—ovarian cancer	3.76e-06	1.17e-05	CbGpPWpGaD
